StockData
Silence Therapeutics plc logo

Silence Therapeutics plc (SLN) stock

SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$19.80+0.00 (0.00%)

Close on Nov 17, 2026Market cap $935.48MP/E –Yield –

Silence Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Silence Therapeutics's gross margin for the twelve months ending Sep 30, 2026 was 95.0%. For fiscal 2025 it was 61.5%, against 72.7% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202561.5%−11.2
FY2024Dec 31, 202472.7%+13.4
FY2023Dec 31, 202359.3%+21.5
FY2022Dec 31, 202237.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 202697.4%+35.4
Q4 FY2025Dec 31, 202564.7%−27.2
Q3 FY2025Sep 30, 202559.7%+202.7
Q2 FY2025Jun 30, 202562.1%+402.9
Q1 FY2025Mar 31, 202562.0%−20.2
Q4 FY2024Dec 31, 202491.9%–
Q3 FY2024Sep 30, 2024-142.9%–
Q2 FY2024Jun 30, 2024-340.9%–
Q1 FY2024Mar 31, 202482.2%–

More Silence Therapeutics figures

See a number that looks wrong?